Comparative Pharmacology
Head-to-head clinical analysis: PENICILLIN 2 versus PROBAMPACIN.
Peer-Reviewed Evidence
Head-to-head clinical analysis: PENICILLIN 2 versus PROBAMPACIN.
PENICILLIN-2 vs PROBAMPACIN
Comparing the clinical profiles, pharmacokinetic behaviors, and safety indices of these two therapeutic agents.
Inhibits bacterial cell wall synthesis by binding to penicillin-binding proteins (PBPs), inhibiting transpeptidase activity, and activating autolytic enzymes.
PROBAMPACIN is a synthetic aminoglycoside antibiotic that inhibits bacterial protein synthesis by binding to the 30S ribosomal subunit, causing misreading of mRNA and preventing translocation of peptidyl-tRNA from the A-site to the P-site.
250 mg orally every 6 hours or 500 mg orally every 8 hours for mild to moderate infections; intravenous dosing: 1-2 million units every 4-6 hours.
100 mg IV every 12 hours over 30 minutes.
None Documented
None Documented
30-60 minutes; prolonged in renal impairment (up to 10 hours in anuria)
4.5 hours (prolonged to 12-18 hours in severe renal impairment)
Renal: 60-80% unchanged; biliary/fecal: minor (10-20%)
Renal: 70% unchanged; biliary/fecal: 20% as metabolites; 10% other
Category C
Category C
Penicillin Antibiotic
Penicillin Antibiotic